Dissertation/Thesis Abstract

Biominetic High Density Lipoproteins for the Delivery of Therapeutic Oligonucleotides
by Tripathy, Sushant, Ph.D., Northwestern University, 2015, 110; 3705384
Abstract (Summary)

Advances in nanotechnology have brought about novel inorganic and hybrid nanoparticles with unique physico-chemical properties that make them suitable for a broad range of applications—from nano-circuitry to drug delivery. A significant part of those advancements have led to ground-breaking discoveries that have changed the approaches to formulation of therapeutics against diseases, such as cancer. Now-a-days the focus does not lie solely on finding a candidate small-molecule therapeutic with minimal adverse effects, but researchers are looking up to nanoparticles to improve biodistribution and biocompatibility profile of clinically proven therapeutics. The plethora of conjugation chemistries offered by currently extant inorganic nanoparticles have, in recent years, led to great leaps in the field of biomimicry—a modality that promises high biocompatibility. Further, in the pursuit of highly specific therapeutic molecules, researchers have turned to silencing oligonucleotides and some have already brought together the strengths of nanoparticles and silencing oligonucleotides in search of an efficacious therapy for cancer with minimal adverse effects. This dissertation work focuses on such a biomimetic platform—a gold nanoparticle based high density lipoprotein biomimetic (HDL NP), for the delivery of therapeutic oligonucleotides.

The first chapter of this body of work introduces the molecular target of the silencing oligonucleotides—VEGFR2, and its role in the progression of solid tumor cancers. The background information also covers important aspects of natural high density lipoproteins (HDL), especially their innate capacity to bind and deliver exogenous and endogenous silencing oligonucleotides to tissues that express their high affinity receptor SRB1. We subsequently describe the synthesis of the biomimetic HDL NP and its oligonucleotide conjugates, and establish their biocompatibility. Further on, experimental data demonstrate the efficacy of silencing oligonucleotides conjugated HDL NPs in regulating the expression and function of VEGFR2 in cultured endothelial cells. Finally, the efficacy of the conjugates in two animal models of angiogenesis is presented.

Indexing (document details)
Advisor: Thaxton, Colby S., Volpert, Olga V.
Commitee: Cheng, Chonghui, Lavker, Robert M.
School: Northwestern University
Department: Integrated Graduate Program in the Life Sciences
School Location: United States -- Illinois
Source: DAI-B 76/10(E), Dissertation Abstracts International
Source Type: DISSERTATION
Subjects: Cellular biology, Nanoscience, Oncology
Keywords: Biomimetic, Endothelial, HDL, Matrigel, Tumor, VEGFR2
Publication Number: 3705384
ISBN: 978-1-321-78321-6
Copyright © 2019 ProQuest LLC. All rights reserved. Terms and Conditions Privacy Policy Cookie Policy
ProQuest